FDA Brief

Warning letters Drugs

FDA warning letter to

Summit Research Peptides

Issued Dec 10, 2024Posted Dec 17, 2024Center for Drug Evaluation and Research (CDER)

Unapproved New Drugs/Misbranded. We haven't summarized this letter yet. Read it on fda.gov.